A gnotobiotic mouse study was investigated to establish a suitable experimental model for evaluating an individual bacterial role for Escherichia coli O157:H7 infection. Germ-free (GF) BALB/c mice (nu/+) were found to die after 12-14 days of E. coli O157:H7 (strain CR 7087) infection, causing rough surface, atrophy, and faded color of the kidney, while specific pathogen-free (SPF) mice survived without any damage after similar infection. Using this model , the effect of Bifidobacterium-monoassociation (BA) and feeding of fructooligosaccharides (FOS) on the lethal activity of enterohemorrhagic E. coli O157:H7 was examined to elucidate if mice inoculated with B. adolescentis strain MBL8321 showed a significantly longer survival time than original GF mice after E. coli O157:H7 (strain CR 7087) infection. An analysis of the biomarkers in the present study provided the following information: 1) B. adolescentis was successfully associated at the 109-1010 colony-forming unit (cfu) level throughout the test period, 2) the numbers of viable E. coli in feces decreased in the order of GF, BA (= BA-FOS) and SPF groups, and the amount of fecal Shiga toxin (Stx), serum creatinine and urea nitrogen also decreased in similar order, 3) the amount of cecal short-chain fatty acids (SCFAs) was found to correlate with the survival time, and 4) the feeding of FOS under this condition afforded no additional increase in either survival time or amount of cecal SCFAs. These results indicate that the study using gnotobiotic mice is suitable for an experimental model of E. coli O157:H7 infection, and suggest that the intestinal microflora plays an important role for preventing E. coli O157 infection in mice. However, the model is not suitable for evaluating the inhibitory effect related to intestinal fermentation because the parameters for fermentation did not change .
INTRODUCTION
Escherichia coli strains of serotype O157:H7 have been implicated as agents responsible for fatal outbreaks of hemorrhagic colitis, hemolytic uremic syndrome and thrombotic thrombosytopeic purpura (9, 13, 17) . These enterohemorrhagic E. coli O157:H7 isolates produce both Stxl and/or Stx2, and these toxins play a critical role in the pathogenesis of diarrhea (15) .
Many researchers have reported that indigenous intestinal bacteria provide a natural barrier that effectively interferes with the colonization of pathogenic bacteria (16, 19) . For example, proliferation of the gastrointestinal bifidobacteria resulting from the intake of viable cell preparations or fermentable oligosaccharides was reported to contribute to the prevention of the growth of Salmonella (1), E. coli (3) and Clostridium difficile (2) . The proposed inhibitory mechanisms include lowering pH (12) , production of inhibitory compounds such as SCFAs and bacteriocins (11) , and competition for nutrients (4) and binding sites on the gut epithelium. This information suggested that the indigenous bifidobacteria also provided some suppressive effect on the infection and disease by E. coli O157. However, in order to cause lethal pathogenicity by E. coli O157 in laboratory animals, an antibiotics-treated mouse model has been used in practice (5, 14, 20) , and this model is not suitable for evaluating the role of intestinal bacteria.
In this study, we tried to contrive a gnotobiotic mouse model suitable for an infection study utilizing E. coli Table 1 , GF and SPF mice were orally challenged by 4 different strains of E. coli in a vinyl isolator. All SPF mice survived even after 14 days, while GF mice died on different survival days depending on the challenged strains. Among these strains, strain CR 7087 was selected to be suitable for the measurement of the antilethal activity of Bifidobacterium and FOSfeeding against E. coli O157 infection in the next experiments since no mouse died within 7 days but all of them were found to die after 14 days. By the challenge of the four strains of E. coli O157, GF mice showed characteristic features in their behaviors: they became lethargic, stopped eating and drinking, and died , although neither diarrhea nor bloody stool was observed .
Antilethal Activity of Bifidobacterium and Feeding of Fructooligosaccharides against E. coli O157 Infection
To evaluate the effect of Bifidobacterium-monoassociation and additional feeding of FOS on the lethal activity of E. coli O157, dual experiments (Exp . 1 and Exp. 2) were carried out to compare the survival time of the associated gnotobiotic mice with those of GF and SPF mice. Exp. 1 consisted of four test groups, GF, Bifidobacterium-monoassociation (BA), BA with FOS-feeding (BA-FOS), and SPF. BA and BA-FOS were treated with oral inoculations of viable B. adolescentis MBL8321 34 days before the challenge of E. coli O157, expecting that the preinoculation would raise the immunological defensive activity of the mouse , and only the BA-FOS group was fed with FOS diets from the inoculation time. All mice of the four groups Tables  2 and  3. E. coli 0157 in the feces of SPF mice was easily recognized because there was no inherent E. coli which resembled 0157 on SMC. As in Table 2 , viable E. coli was found in all feces of the test groups, but the numbers decreased in the order of GF, BA (= BA-FOS), and SPF. The statistical analyses after each interval are shown in Table 2 , indicating that a significant difference is recognized among three groups, GA, BA (=BA-FOS), and SPF. However, the GF group gave no reliable figure after 22 days because of only one surviving mouse. Fecal viable Bifidobacterium were colonized at high levels in two Bifidobacterium-monoassociated groups, and no statistical difference in the level was found between the BA and BA-FOS groups. As in Table  3 , considerable numbers of both E. coli and Bifidobacterium were found in the liver as reported in the case of E. coli O111:K58 (21), indicating that both bacteria easily translocated to the liver in this condition. The ratios of detected mice were lower in the BA-FOS and SPF groups. Particularly high values of both Stxl and Stx2 were found in the cecal contents of the GF group, the values decreased in the BA and BA-FOS mice, and no toxins were detected in SPF mice. Comparing the titer value of extracellular and intracellular Stx, there was no significant difference among the test groups. Damage of kidney was referred to as measured concentrations of creatinine and urea nitrogen in serum by commercially available enzymatic kits using the Jaffe method (Creatinine-test wako, Wako Chemical Indus- Table 2 . Viable bacterial numbers1) of E. coli O157:H7 and B. adolescentis MBL8321 in the feces of mice. tries, Ltd.) and Urease-indophenol method (Urease-nitrogen B-test wako, Wako Chemical Industries, Ltd.), respectively. As shown in Table 3 , the highest values of both parameters were observed in the GF group. The concentration and composition of the SCFAs in the cecal contents of the four test groups are shown in Fig. 2 . The highest concentration was in the SPF group and the lowest was in the GF group. A statistically significant difference in the SPF group was recognized among the three groups (SPF and BA (p < 0.01), SPF and BA-FOS (p < 0.01), and BA and BA-FOS (p = 0.26)), although the GF group afforded no statistical value because there was only one sample. Regarding the composition of SCFAs, only the SPF group had five components, although the other three groups had three common components.
DISCUSSION
The reproducible results that Bifidobacterium-associated and SPF mice had statistically longer survival times than that of GF mice suggest that the intestinal microflora plays an important role in the prevention of E. coli O157 infection in mice. The similarity of survival features of BA and BS in Exp. 2 of Fig. 1 sug- gests the existence of a direct suppressive action of Bifidobacterium-monoassociation against the lethal activity of E. coli O157:H7, but the reason is unclear. The observation does not coincide with that of a previous report in which total immunoglobulin A and cellmediated immune activity, induced by the monoassociation of Bifidobacterium with GF mice for 4 to 6 weeks, seemed to play an important role in protecting enteropathogens (22) . The statistical analysis of viable numbers of fecal E. coli 0157 (shown in Table 2 ) and cecal SCFA concentration (shown in Fig. 2 ) reveal an interesting observation, that the increase in viable E. coli numbers was inverse in relation to the increase in cecal SCFA concentrations among the four test groups. A few previous papers reported that the intestinal concentration of SCFAs inhibited the growth of E. coli and other bacteria in vitro (4, 11) , and these papers supports our data. The difference in cecal composition of the SCFAs between the three Bifidobacterium-monoassociated groups and SPF group is ascribed to the difference of species number in the intestine. This result suggests that the concentration or components of intestinal SCFAs play a suppressive role in the growth of intestinal E. coli O 157:H7 in this in vivo model.
It is well-known that nondigestible saccharides are fermented by intestinal bacteria to produce SCFAs (6, 11) . But in this study, as shown in Fig. 2 , SCFAs in the cecal contents did not increase by the additional feeding of FOS in the BA-FOS group, although the concentration of SCFAs in the SPF group was very high. According to this result, it can be presumed that the gastrointestinal circumstances of the GF mouse are different from those of conventional animals. Hoskins and Zamchec (8) reported that the intestine of GF mice maintained so much nutrients from the gastrointestinal mucins, that it enabled Bifidobacterium in the BA group to grow to the high level of 1010-order without the addition on FOS. In fact, the cecal microflora of the BA and BA-FOS groups were proved to have a capability to produce SCFAs by the addition of FOS, followed by in vitro fermentation (see Fig. 3 ). Currently, we have no obvious information why SCFAs in the cecal contents did not increase with the additional feeding of FOS, but we speculated that FOS can be fermented without detecting a high amount of SCFAs in the cecal contents, or FOS cannot reach the cecum of GF mice for some reason.
The results in this study indicate that the gnotobiotic mouse is applicable as a suitable experimental model to evaluate the suppressive effect of intestinal bacteria on infection by E. coli O157.
